Upregulation of tumor suppressor protein neurofibromin in normal human wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor-β1 (TGF-β1) elicited increase in neurofibromin mRNA steady-state levels in dermal fibroblasts

Journal of Investigative Dermatology

Volumn 110, Issue 3, 1998, Pages 232-237

  Ylä Outinen, Heli ^a,b   Aaltonen, Vesa ^a   Björkstrand, Ann Sofi ^a   Hirvonen, Outi ^a   Lakkakorpi, Jouni ^b   Vähä Kreula, Marko ^a   Laato, Matti ^a   Peltonen, Juha ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Neurofibromatosis; Pathogenesis; Scar; Tissue repair

Indexed keywords

NEUROFIBROMIN; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FETUS; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEUROFIBROMATOSIS; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCAR; SCHOOL CHILD; SKIN INJURY; TISSUE REPAIR; WOUND HEALING;

EID: 0031919430     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00108.x     Document Type: Article

References (54)

1. Åkesson HO, Axelsson R, Samuelsson B: Neurofibromatosis in monozygotic twins: a case report. Acta Genet Med Gemellol (Roma) 32:245-249, 1983
2. Andersen LB, Ballester R, Marchuk DA, et al: A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol 13:487-495, 1993a
3. Andersen LB, Fountain JW, Gutmann DH, et al: Mutations in the neurofibromatosis I gene in sporadic malignant melanoma cell lines. Nat Genet 3:118-121, 1993b
4. Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J: Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356:713-715, 1992
5. Bollag G, McCormick F: Ras regulation. NF is enough of GAP. Nature 356:663-664, 1992
6. Bollag G, McCormick F, Clark R: Characterization of full length neurofibromin: tubulin inhibits RAS GAP activity. EMBO J 12:1923-1927, 1993
7. Bornfeldt KE, Raines EW, Graves LM, Skinner MP, Krebs EG, Ross R: Platelet-derived growth factor. Distinct signal transduction pathways associated with migration vs. proliferation. Ann NY Acad Sci 766:416-430, 1995
8. Brannan CI, Perkins AS, Vogel KS, et al: Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 8:1019-1029, 1994
9. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochem 18:5294-5299, 1979
10. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann Biochem 162:156-159, 1987
11. ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69:265-273, 1992
12. von Deimling A, Krone W, Menon AG: Neurofibromatosis type 1: pathology, clinical features and molecular genetics. Brain Pathol 5:153-162, 1995
13. Eccleston PA, Funa K, Heldin CH: Expression of plateled-derived growth factor (PDGF) and PDGF alpha- and beta-receptors in the peripheral nervous system: an analysis of sciatic nerve and dorsal root ganglion. Dev Biol 155:459-470, 1993
14. Fleischmajer R, Timpl R, Dziadek M, Lebwohl M: Basement membrane proteins, interstitial collagens, and fibronectin in neurofibroma. J Invest Dermatol 85:54-59, 1985
15. Golubic M, Roudebush M, Dobrowolski S, Wolfman A, Stacey DW: Catalytic properties, tissue and intracellular distribution of neurofibromin. Oncogene 7:2151-2159, 1992
16. Gregory PE, Gutmann DH, Mitchell A, et al: Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules. Somat Cell Mol Genet 19:265-274, 1993
17. Gutmann DH, Wood DL, Collins FS: Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci USA 88:9658-9662, 1991
18. Gutmann DH, Geist RT, Rose K, Wright DE: Expression of two new protein isoforms of the neurofibromatosis type 1 gene product, neurofibromin, in muscle tissues. Dev Dyn 202:302-311, 1995
19. Gutmann DH, Giordano MJ, Mahadeo DK, Lau N, Silbergeld D, Guha A: Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras. Oncogene 12:2121-2127, 1996
20. Hardy M, Reddy UR, Pleasure D: Plateled-derived growth factor and regulation of Schwann cell proliferation in vivo. J Neurosci Res 31:254-262, 1992
21. Hart CE, Forstrom JW, Kelly JD, et al: Two classes of PDGF receptor recognize different isoforms of PDGF. Sci 240:1529-1531, 1988
22. Heldin CH, Westermark B: Role of platelet-derived growth factor in vivo. In: Clark RAF (ed.). The Molecular and Cellular Biology of Wound Repair, 2nd edn. Plenum Press, New York, 1996, pp. 249-273
23. Hermonen J, Hirvonen O, Ylä-Outinen H, et al: Neurofibromin: expression by normal human keratinocytes in vivo and in vitro, and in epidermal malignancies. Lab Invest 73:221-228, 1995
24. Huson SM: Neurofibromatosis 1: a clinical overview. In: Huson SM, Hughes RAC (eds). The Neurofibromatoses, a Pathogenetic and Clinical Overview. Chapman & Hall, London, 1994, pp. 160-203
25. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA: Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nature Genet 7:353-361, 1994
26. Johnson MR, Look AT, DeClue JE, Valentine MB, Lowy DR: Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP.Ras. Proc Natl Acad Sci USA 90:5539-5543, 1993
27. ras, inhibition of cell proliferation and morphological changes. Oncogene 11:325-335, 1995
28. Kobayashi M, Hashimoto N, Hoshino M, Hattori S, Iwashita S: Differential contribution of M (r) 120 kDa rasGTPase-activating protein and neurofibromatosis type 1 gene product during the transition from growth phase to arrested state in human fibroblasts accompanied by a unique rasGTPase-activating activity. FEBS Lett 327:177-182, 1993
29. Lassmann H, Gebhart W, Stockinger L: The reaction of connective tissue fibers in the tumor of Recklinghausen's disease. Virhows Arch B Cell Pathol 19:167-177, 1975
30. Legius E, Marchuk DA, Collins FS, Glover TW: Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 3:122-126, 1993
31. Li Y, Bollag G, Clark R, et al: Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69:275-281, 1992
32. Marchuk DA, Saulino AM, Tavakkol R, et al: cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 11:931-940, 1991
33. Meyer-Ingold W, Eichner W: Platelet-derived growth factor. Cell Biol Int 19:389-398, 1995
34. Morcos P, Thapar N, Tusneem N, Stacey D, Tamanoi F: Identification of neurofibromin mutants that exhibit allele specifity or increased Ras affinity resulting in suppression of activated ras alleles. Mol Cell Biol 16:2496-2503, 1996
35. Nishi T, Lee PS, Oka K, Levin VA, Tanase S, Morino Y, Saya H: Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation. Oncogene 6:1555-1559, 1991
36. Nudel U, Zakut R, Shani M, Neuman S, Levy Z, Yaffe D: The nucleotide sequence of the rat cytoplasmic β-actin gene. Natl Acid Res 11:1759-1771, 1983
37. Peltonen J, Foidart JM, Aho HJ: Type IV and V collagens in von Recklinhausen's neurofibromas. An immunohistochemical and electophoretical study. Virhows Arch B Cell Pathol Ind Mol Pathol 47:291-301, 1984
38. Peltonen J, Penttinen R, Larjava H, Aho HJ: Collagens in neurofibromas and neurofibroma cell cultures. Ann N Y Acad Sci 486:260-270, 1986
39. Peltonen J, Jaakkola S, Lebwohl M, Renvall S, Risteli L, Virtanen I, Uitto J: Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest 59:760-771, 1988
40. Peltonen J, Karvonen S-L, Ylä-Outinen H, Hirvonen O, Karvonen J: Lesional psoriatic epidermis displays reduced neurofibromin immunoreactivity. J Invest Dermatol 105:664-667, 1995
41. Riccardi VM: Cutaneous manifestations of neurofibromatosis: cellular interaction. pigmentation and mast cells. Birth Defects 17:129-145, 1981
42. Riccardi VM: The potential role of trauma and mast cells in the pathogenesis of neurofibromas. In: Ishibashi Y, Hori Y (eds). Tuberous Sclerosis and Neurofibromatosis: Epidemiology, Pathophysiology, Biology and Management. Elsevier Science, Amsterdam, 1990, pp. 167-190
43. Roberts AN, Sporn MB: Transforming growth factor-β. In: Clark RAF (ed.). The Molecular and Cellular Biology of Wound Repair, 2nd edn. Plenum Press, New York, 1996, pp. 275-308
44. Satoh T, Fantl WJ, Escobedo JA, Williams LT, Kaziro Y: Platelet-derived growth factor receptor mediates activation of ras through different signalling pathways in different cell types. Mol Cell Biol 13:3706-3713, 1993
45. Seifert RA, Hart CE, Phillips PE, Forstrom JW, Ross R, Murray MJ, Bowen-Pope DF: Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem 264:8771-8778, 1989
46. Sosnowski RG, Feldman S, Feramisco JR: Interference with endogenous ras functon inhibits cellular responses to wounding. J Cell Biol 121:113-119, 1993
47. Teruel T, Valverde AM, Benito M, Lorenzo M: Transforming growth factor beta 1 induces mitogenesis in fetal rat brown adipocytes. J Cell Physiol 166:577-584, 1996
48. The I, Murthy AE, Hannigan GE, Jacoby LB, Menon AG, Gusella JF, Bernards A: Neurofibromatosis type 1 gene mutations in neuroblastoma. Nat Genet 3:62-66, 1993
49. Uitto J, Matsuoka LY, Chu ML, Pihlajaniemi T, Prockop DJ: Connective tissue biochemistry of neurofibromas. Ann N Y Acad Sci 486:271-286, 1986
50. Vogel KS, Brannan CI, Jenkins NA, Copeland NG, Parada LF: Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons. Cell 82:733-742, 1995
51. Wallace MR, Marchuk DA, Andersen LB, et al: Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Sci 249:181-186, 1990
52. Wrabetz L, Feltri ML, Kim H, Dastom M, Kamholz J, Scherer SS, Ratner N: Regulation of neurofibromin expression in rat sciatic nerve and cultured Schwann cells. GLIA 15:22-32, 1995
53. Xu G, O'Connel P, Viskochil D, et al: The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599-608, 1990
54. Yan Z, Winawer S, Friedman E: Two different signal transduction pathways can be activated by transforming growth factor beta 1 in epithelial cells. J Biol Chem 269:13231-13237, 1994